The other half of the bolus of patients we’re talking about consists of those who have never been treated
The problem with treating this group is that most do not even know they have the virus.Its not going to be easy to mine them . This was the great hope of the Orasure product for use in the General medicine office.The only time these patients are even flagged are when elevated ALts show up . That happens in about 50 % of patients . Its too bad most GP Dr's don't even catch that
Don't know where you are getting your estimates of "roughly half" from, but I won't argue them because I don't have anything better.
Just a caution that the "roughly half" never treated might be never treated for a reason. And tolerability of the SOC, which is only going to get worse in the short term, may have something to do with it.
Market Data 
Markets 
AI
